Pfizer Could Prove Underrated GLP-1 Stock Opportunity
Pfizer may be sitting on a hidden GLP-1 opportunity. This article breaks down why the company could prove to be an un...
Regularly reviewing your retirement plan is essential for long-term success. Find out when to make those important assessments.
20,077 articlesPfizer may be sitting on a hidden GLP-1 opportunity. This article breaks down why the company could prove to be an un...
Sweetgreen faced a rough spell as the market punished sweetgreen that once looked unstoppable. Now, smart investors w...
AI funding is surging in 2026, signaling a new investment wave. Here's how an investor ahead next investment can posi...
A stock split made shares cheaper, but the real driver of Amazon’s rally is its expanding AI and cloud empire. Here’s...
Meta unveils a $6.5 billion plan to manufacture next-gen MTIA AI chips with Samsung Foundry, aiming to strengthen its...
A speculative analysis explores a spacex-tesla merger valued at $3.4 trillion and explains why such a mega-deal might...
As memory cycles swing, the safest play in July may not be the pure-play chips you expect. This article explains why ...
Oracle shares hover near $144 as AI infrastructure demand meets cash-flow headwinds. A rising backlog and lofty reven...
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
A sharp look at how Rivian Automotive and Tesla earn money, where their revenue comes from, and what the trends mean ...
Oil markets swung dramatically in the first half, with prices surging and then cooling. This guide explains what that...
Oracle stock sinks to a fresh 52-week low as a rating downgrade raises capital-structure questions while AI ambitions...